Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash Flows from Operating Activities
Net loss	$ (3,338,732)	$ (2,311,798)
Adjustments to reconcile net loss to net cash used in operating activities:
Noncash stock-based compensation expense	1,004,385	493,397
Amortization of ROU assets	55,675	18,087
Depreciation and amortization	26,957	10,366
Loss on disposal of asset	14,540	1,503
PPP loan forgiveness		(81,550)
Amortization of future compensation payable	416,666	416,667
Amortization of prepaid assets	104,169	82,194
Changes in assets and liabilities:
Accounts receivable	(190,922)
Other assets	(217,023)	(48,219)
ROU liabilities	(32,049)	(8,401)
Accounts payable	(99,304)	(32,520)
Accrued interest		660
Accrued expenses and compensation	42,290	59,982
Net cash used in operating activities	(2,213,347)	(1,399,632)
Cash Flows from Investing Activities
Purchase of equipment	(40,982)	(74,142)
Net cash used in investing activities	(40,982)	(74,142)
Cash Flows from Financing Activities
Proceeds from sale of common stock		2,258,000
Repayment on note payable	(77,971)	(1,052,093)
Proceeds from note payable	175,435
Repayment of SBA loan	(23,553)
Proceeds from the exercise of stock option	13,000	71,000
Net cash provided by financing activities	86,911	1,276,907
Net change in cash and cash equivalents	(2,167,418)	(196,867)
Cash and cash equivalents, beginning of year	3,662,615	3,323,290
Cash and cash equivalents, end of year	1,495,197	3,126,423
Supplemental disclosure of cash flow information
Cash paid for interest	1,683	1,241
Cash paid for taxes
Non-cash investing and financing activities
Insurance financing for prepaid insurance	175,435	117,209
Implementation of ASC 842		617,569
Forgiveness of PPP loan		81,550
Equipment investing in accounts payable		64,107
Common stock issued for repayment of convertible notes		$ 47,499